Analyst Price Targets — KALA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 30, 2025 1:32 pm | — | Mizuho Securities | $1.50 | $1.81 | TheFly | Kala Bio downgraded to Neutral from Outperform at Mizuho |
| September 17, 2025 10:19 am | — | H.C. Wainwright | $35.00 | $17.47 | TheFly | Kala Pharmaceuticals price target raised to $35 from $12 at H.C. Wainwright |
| August 7, 2024 6:18 am | Yi Chen | H.C. Wainwright | $7.50 | $3.10 | TheFly | Kala Pharmaceuticals price target lowered to $15 from $18 at H.C. Wainwright |
| May 17, 2024 10:34 am | Yi Chen | H.C. Wainwright | $9.00 | $3.25 | TheFly | Kala Pharmaceuticals price target lowered to $18 from $21 at H.C. Wainwright |
| April 3, 2024 6:43 am | Yi Chen | H.C. Wainwright | $10.50 | $4.00 | StreetInsider | Kala Pharmaceuticals (KALA) PT Lowered to $21 at H.C. Wainwright |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for KALA

AI-powered autonomous research agents to be deployed in support of PEX010 clinical development strategy, leveraging Kala Bio's purpose-built agentic AI platform for the biotechnology industry TORONTO and ARLINGTON, Mass., March 18, 2026 (GLOBE NEWSWIRE) -- Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light” or the “Company”) and Kala Bio, Inc. (NASDAQ: KALA) (“Kala Bio”) today announced that…

AI-powered autonomous research agents to be deployed in support of PEX010 clinical development strategy, leveraging Kala Bio's purpose-built agentic AI platform for the biotechnology industry Toronto, Ontario and Arlington, Massachusetts--(Newsfile Corp. - March 18, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Kala Bio, Inc. (NASDAQ: KALA) ("Kala Bio")…

Open-source breakthrough demonstrates AI agents can run 100+ experiments overnight-reinforcing the agentic R&D paradigm Researgency.ai is bringing to life sciences with Kala Bio (KALA) Toronto, Ontario--(Newsfile Corp. - March 11, 2026) - Younet.ai, a Toronto-based AI technology company specializing in enterprise-grade private LLM solutions, today announced that the recent release of AutoResearch by AI pioneer…

Platform Rebrand of Researgency.ai; First Purpose-Built AI Agent for Biotech Expected to Ship Within Two Weeks Platform Rebrand of Researgency.ai; First Purpose-Built AI Agent for Biotech Expected to Ship Within Two Weeks

Younet AI Partners with KALA BIO to Deploy AI Infrastructure for the Biotech Industry Vancouver, British Columbia--(Newsfile Corp. - March 9, 2026) - Stock Trend Capital Inc. (CSE: STCQ) (FSE: P0G) (OTC Pink: STOCF) (the "Company" or "Stock Trend") is pleased to provide shareholders with an update regarding its investment in Younet AI ("Younet"), a privately held Canadian company developing artificial-intelligence…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for KALA.
U.S. House Trading
No House trades found for KALA.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
